Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated the effectiveness and safety of epoetin alfa during autologous blood donation before surgery. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 3 | Status: COMPLETED